Entoura Launches Digital Platform to Help Veterans Apply for Medicinal Cannabis Funding

The company launched the platform as part of its commitment to improving former soldiers' health by addressing the unique needs of Australia's Veteran community.

The Melbourne-based cannabis company, Entoura Pty Ltd, announced today that it will launch a proprietary digital solution for submitting applications to the Department of Veterans' Affairs (DVA) for medicinal cannabis funding.

The automated process will be made available to doctors and medical specialists free of charge, allowing them to generate a funding application quickly and easily for DVA patients.

Veterans suffer stress, pain and anxiety both on the field and on return home. It is vitally important that they have ready access to medicinal cannabis, which is invaluable in the management of the many conditions that veterans suffer. Medicinal cannabis is very effective, has very few side effects and is not addictive. Properly prescribed, medicinal cannabis can greatly enhance a veterans quality of life.Australasian College of Nutritional and Environmental Medicine, Professor Ian Brighthope

The company launched the platform as part of its commitment to improving Veterans' health by addressing the unique needs of Australia's veteran community.

Aside from simplifying the application process, Entoura's new online platform also promises to operate considerably faster than the current system, allowing patients to receive an approval for funding in days, rather than weeks or months.  

According to Entoura's General Manager, Clare Barker, the company's digital platform will have the capacity to, "generate the application for DVA funding of medicinal cannabis in a first for Australian prescribers."

"The tool 'demystifies' the application process for those doctors who are looking to improve their patients' quality of life by facilitating funded access to medicinal cannabis."

"Designed to cut through the red tape and the time-consuming process of applying for DVA funding, this tool is a simple step that ensures all the DVA requirements are met."

"We believe this is an important way that Entoura can provide much needed support to veterans and their doctors," Barker said.

The company hopes that healthcare providers will be able to use the platform to cut down on waiting periods and find, "a faster route to supporting the health needs of our Veterans."

Any doctors or medical specialists who are searching for assistance in submitting the application can register for the Entoura Cannabis Support Portal. Alternately, if you'd like learn more about the application process for DVA funded medical cannabis please visit honahlee, which currently serves as one of Entoura's digital education partners.


This pot stock could reach new heights in 2020 due to Coronavirus

The COVID-19 pandemic is showing no signs of slowing down, and as global markets enter meltdown many cannabis companies are feeling the effects of capital crunch.

While the market crash will continue for some time, it represents a golden opportunity for investors who are capable of riding out the volatility until share prices rally.

Luckily, one pot stock has developed antimicrobial drug that can already treat two superbugs while limiting their ability to develop antibiotic resistance.

Investors can also start picking up shares at rock bottom prices, as global investor sentiment continues to dampen thanks to COVID-19.

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Hugo Gray
Hugo Gray

Hugo Gray is a Melbourne-based journalist with a body of work that covers a diverse range of topics, including immigration law, sex technology, and now the rapidly expanding cannabis industry.

Leave a Reply

Your email address will not be published. Required fields are marked *